AMY HENSON: Open Payments
NPI 1952556680 · WEATHERFORD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,984 in 75 payments from 25 companies in 2025. Trend: 2023 $1,362 · 2024 $2,334 · 2025 $1,984
Food & beverage: $1,984
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $283 |
| PFIZER INC. | 10 | $248 |
| AstraZeneca Pharmaceuticals LP | 6 | $207 |
| ABBVIE INC. | 13 | $162 |
| Amgen Inc. | 7 | $158 |
| Lilly USA, LLC | 4 | $153 |
| JAZZ PHARMACEUTICALS INC. | 1 | $128 |
| Supernus Pharmaceuticals, Inc. | 1 | $122 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $68 |
| Neurocrine BioSciences, Inc. | 2 | $67 |
Products named: NURTEC ODT, Wegovy, JARDIANCE, REPATHA, XYWAV, Qelbree, BREZTRI, VRAYLAR.
Industry payments across TX — which companies pay providers there.
